Study to Improve Renal Function After Kidney Transplantation
Status:
Unknown status
Trial end date:
2016-02-01
Target enrollment:
Participant gender:
Summary
The objective of the study is to evaluate the safety and activity of a investigational drug
in improving renal function in patients who have undergone renal transplantation and have
signs and symptoms of significant renal injury and are at risk for dialysis.
Phase:
Phase 2
Details
Lead Sponsor:
Angion Biomedica Corp
Collaborator:
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)